# Novo Nordisk CEO Testifies on Ozempic Prices – Novo Nordisk’s CEO, Lars Fruergaard Jorgensen, faced questioning from the House Committee on Oversight and Reform regarding the pricing of Ozempic. – Jorgensen defended the price of Ozempic, a drug used in the treatment of type 2 diabetes, citing research and development costs as well as patient assistance programs. – The CEO highlighted the importance of ensuring that patients have access to necessary medications while also balancing the need for innovation and sustainability in the pharmaceutical industry. ## Hot Take: While the pricing of medications like Ozempic may be a topic of debate, it is crucial to acknowledge the efforts made by pharmaceutical companies to support patients through assistance programs. Ensuring access to vital medications while fostering innovation is a delicate balance that requires ongoing dialogue and collaboration. Weight Loss Disclaimer: Always consult with a healthcare provider before starting any weight loss program. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact Mindful Evolution on our website https://yourmindfulevolution.com or call or text us at 954-639-9960.